nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—SERPINA6—Beclomethasone—psoriasis	0.16	0.194	CbGbCtD
Mitotane—SERPINA6—Fluocinolone Acetonide—psoriasis	0.16	0.194	CbGbCtD
Mitotane—SERPINA6—Fluocinonide—psoriasis	0.16	0.194	CbGbCtD
Mitotane—CYP11A1—Cholecalciferol—psoriasis	0.0811	0.0983	CbGbCtD
Mitotane—CYP11B1—Hydrocortisone—psoriasis	0.0674	0.0817	CbGbCtD
Mitotane—SERPINA6—Triamcinolone—psoriasis	0.0636	0.0771	CbGbCtD
Mitotane—SERPINA6—Prednisolone—psoriasis	0.0538	0.0653	CbGbCtD
Mitotane—SHBG—Hydrocortisone—psoriasis	0.0448	0.0543	CbGbCtD
Mitotane—CYP11A1—Dexamethasone—psoriasis	0.0351	0.0425	CbGbCtD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.0028	0.163	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00227	0.132	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—CYP2S1—psoriasis	0.0012	0.0704	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000996	0.0582	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000983	0.0575	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000852	0.0498	CbGpPWpGaD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000841	0.0492	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—IVL—psoriasis	0.000832	0.0486	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000807	0.0472	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—IVL—psoriasis	0.000712	0.0416	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000691	0.0404	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—CYP2S1—psoriasis	0.000429	0.0251	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—CYP2S1—psoriasis	0.000423	0.0247	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—CYP2S1—psoriasis	0.000367	0.0215	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000362	0.0212	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NDUFA5—psoriasis	0.000242	0.0142	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000226	0.0132	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP2S1—psoriasis	0.000206	0.012	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—NFKBIA—psoriasis	0.000154	0.009	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—NFKBIA—psoriasis	0.000132	0.0077	CbGpPWpGaD
Mitotane—Vision blurred—Prednisolone—psoriasis	0.000114	0.000723	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000113	0.000713	CcSEcCtD
Mitotane—Hypertension—Mycophenolate mofetil—psoriasis	0.000112	0.00071	CcSEcCtD
Mitotane—Visual impairment—Dexamethasone—psoriasis	0.000112	0.000709	CcSEcCtD
Mitotane—Visual impairment—Betamethasone—psoriasis	0.000112	0.000709	CcSEcCtD
Mitotane—Feeling abnormal—Mycophenolic acid—psoriasis	0.000111	0.000701	CcSEcCtD
Mitotane—Breast disorder—Methotrexate—psoriasis	0.00011	0.000699	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.00011	0.000696	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CXCL8—psoriasis	0.00011	0.00642	CbGpPWpGaD
Mitotane—Diarrhoea—Hydroxyurea—psoriasis	0.00011	0.000695	CcSEcCtD
Mitotane—Confusional state—Cyclosporine—psoriasis	0.00011	0.000694	CcSEcCtD
Mitotane—Dysgeusia—Triamcinolone—psoriasis	0.000109	0.000691	CcSEcCtD
Mitotane—Vertigo—Prednisolone—psoriasis	0.000109	0.000689	CcSEcCtD
Mitotane—Eye disorder—Dexamethasone—psoriasis	0.000108	0.000687	CcSEcCtD
Mitotane—Eye disorder—Betamethasone—psoriasis	0.000108	0.000687	CcSEcCtD
Mitotane—Infection—Cyclosporine—psoriasis	0.000108	0.000684	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000108	0.00631	CbGpPWpGaD
Mitotane—Confusional state—Mycophenolate mofetil—psoriasis	0.000107	0.000677	CcSEcCtD
Mitotane—Nervous system disorder—Cyclosporine—psoriasis	0.000107	0.000675	CcSEcCtD
Mitotane—Thrombocytopenia—Cyclosporine—psoriasis	0.000106	0.000674	CcSEcCtD
Mitotane—Vertigo—Hydrocortisone—psoriasis	0.000106	0.000673	CcSEcCtD
Mitotane—Body temperature increased—Mycophenolic acid—psoriasis	0.000106	0.000673	CcSEcCtD
Mitotane—Dizziness—Hydroxyurea—psoriasis	0.000106	0.000672	CcSEcCtD
Mitotane—Skin disorder—Cyclosporine—psoriasis	0.000106	0.000669	CcSEcCtD
Mitotane—Angiopathy—Dexamethasone—psoriasis	0.000105	0.000667	CcSEcCtD
Mitotane—Angiopathy—Betamethasone—psoriasis	0.000105	0.000667	CcSEcCtD
Mitotane—Infection—Mycophenolate mofetil—psoriasis	0.000105	0.000667	CcSEcCtD
Mitotane—Hypertension—Prednisolone—psoriasis	0.000105	0.000663	CcSEcCtD
Mitotane—Shock—Mycophenolate mofetil—psoriasis	0.000104	0.000661	CcSEcCtD
Mitotane—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000104	0.000658	CcSEcCtD
Mitotane—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000104	0.000657	CcSEcCtD
Mitotane—Anorexia—Cyclosporine—psoriasis	0.000104	0.000656	CcSEcCtD
Mitotane—Skin disorder—Mycophenolate mofetil—psoriasis	0.000103	0.000652	CcSEcCtD
Mitotane—Hypertension—Hydrocortisone—psoriasis	0.000102	0.000647	CcSEcCtD
Mitotane—Vomiting—Hydroxyurea—psoriasis	0.000102	0.000646	CcSEcCtD
Mitotane—Rash—Hydroxyurea—psoriasis	0.000101	0.00064	CcSEcCtD
Mitotane—Anorexia—Mycophenolate mofetil—psoriasis	0.000101	0.00064	CcSEcCtD
Mitotane—Dermatitis—Hydroxyurea—psoriasis	0.000101	0.00064	CcSEcCtD
Mitotane—FDX1—Metabolism—CARM1—psoriasis	0.000101	0.00588	CbGpPWpGaD
Mitotane—Headache—Hydroxyurea—psoriasis	0.0001	0.000636	CcSEcCtD
Mitotane—Vertigo—Triamcinolone—psoriasis	0.0001	0.000634	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.0001	0.000634	CcSEcCtD
Mitotane—Connective tissue disorder—Prednisone—psoriasis	9.94e-05	0.000629	CcSEcCtD
Mitotane—Hypotension—Mycophenolate mofetil—psoriasis	9.9e-05	0.000627	CcSEcCtD
Mitotane—Neutropenia—Methotrexate—psoriasis	9.87e-05	0.000625	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—NFKB1—psoriasis	9.82e-05	0.00574	CbGpPWpGaD
Mitotane—Paraesthesia—Cyclosporine—psoriasis	9.75e-05	0.000618	CcSEcCtD
Mitotane—Shock—Prednisolone—psoriasis	9.73e-05	0.000616	CcSEcCtD
Mitotane—Somnolence—Cyclosporine—psoriasis	9.66e-05	0.000612	CcSEcCtD
Mitotane—Asthenia—Mycophenolic acid—psoriasis	9.63e-05	0.00061	CcSEcCtD
Mitotane—Hypertension—Triamcinolone—psoriasis	9.62e-05	0.000609	CcSEcCtD
Mitotane—Infection—Hydrocortisone—psoriasis	9.59e-05	0.000608	CcSEcCtD
Mitotane—Dyspepsia—Cyclosporine—psoriasis	9.56e-05	0.000606	CcSEcCtD
Mitotane—Nausea—Hydroxyurea—psoriasis	9.52e-05	0.000603	CcSEcCtD
Mitotane—Paraesthesia—Mycophenolate mofetil—psoriasis	9.52e-05	0.000603	CcSEcCtD
Mitotane—Shock—Hydrocortisone—psoriasis	9.5e-05	0.000602	CcSEcCtD
Mitotane—Nervous system disorder—Hydrocortisone—psoriasis	9.47e-05	0.0006	CcSEcCtD
Mitotane—Eye disorder—Prednisone—psoriasis	9.45e-05	0.000599	CcSEcCtD
Mitotane—Decreased appetite—Cyclosporine—psoriasis	9.44e-05	0.000598	CcSEcCtD
Mitotane—Somnolence—Mycophenolate mofetil—psoriasis	9.42e-05	0.000597	CcSEcCtD
Mitotane—Drowsiness—Methotrexate—psoriasis	9.41e-05	0.000596	CcSEcCtD
Mitotane—Infestation NOS—Methotrexate—psoriasis	9.41e-05	0.000596	CcSEcCtD
Mitotane—Infestation—Methotrexate—psoriasis	9.41e-05	0.000596	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.4e-05	0.00549	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CXCL8—psoriasis	9.39e-05	0.00549	CbGpPWpGaD
Mitotane—Flushing—Prednisone—psoriasis	9.38e-05	0.000595	CcSEcCtD
Mitotane—Gastrointestinal disorder—Cyclosporine—psoriasis	9.38e-05	0.000594	CcSEcCtD
Mitotane—Skin disorder—Hydrocortisone—psoriasis	9.38e-05	0.000594	CcSEcCtD
Mitotane—Dyspepsia—Mycophenolate mofetil—psoriasis	9.33e-05	0.000591	CcSEcCtD
Mitotane—Pain—Cyclosporine—psoriasis	9.29e-05	0.000589	CcSEcCtD
Mitotane—Decreased appetite—Mycophenolate mofetil—psoriasis	9.21e-05	0.000584	CcSEcCtD
Mitotane—Anorexia—Hydrocortisone—psoriasis	9.2e-05	0.000583	CcSEcCtD
Mitotane—Diarrhoea—Mycophenolic acid—psoriasis	9.19e-05	0.000582	CcSEcCtD
Mitotane—Angiopathy—Prednisone—psoriasis	9.17e-05	0.000581	CcSEcCtD
Mitotane—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	9.15e-05	0.00058	CcSEcCtD
Mitotane—Vertigo—Dexamethasone—psoriasis	9.08e-05	0.000575	CcSEcCtD
Mitotane—Vertigo—Betamethasone—psoriasis	9.08e-05	0.000575	CcSEcCtD
Mitotane—Pain—Mycophenolate mofetil—psoriasis	9.06e-05	0.000574	CcSEcCtD
Mitotane—Infection—Triamcinolone—psoriasis	9.03e-05	0.000572	CcSEcCtD
Mitotane—Hypotension—Hydrocortisone—psoriasis	9.02e-05	0.000572	CcSEcCtD
Mitotane—Haematuria—Methotrexate—psoriasis	8.97e-05	0.000569	CcSEcCtD
Mitotane—Feeling abnormal—Cyclosporine—psoriasis	8.95e-05	0.000567	CcSEcCtD
Mitotane—Shock—Triamcinolone—psoriasis	8.94e-05	0.000567	CcSEcCtD
Mitotane—Hepatobiliary disease—Methotrexate—psoriasis	8.9e-05	0.000564	CcSEcCtD
Mitotane—Dizziness—Mycophenolic acid—psoriasis	8.88e-05	0.000563	CcSEcCtD
Mitotane—Paraesthesia—Prednisolone—psoriasis	8.88e-05	0.000562	CcSEcCtD
Mitotane—Mental disorder—Prednisone—psoriasis	8.86e-05	0.000561	CcSEcCtD
Mitotane—Malnutrition—Prednisone—psoriasis	8.8e-05	0.000558	CcSEcCtD
Mitotane—Feeling abnormal—Mycophenolate mofetil—psoriasis	8.73e-05	0.000553	CcSEcCtD
Mitotane—Hypertension—Betamethasone—psoriasis	8.73e-05	0.000553	CcSEcCtD
Mitotane—Hypertension—Dexamethasone—psoriasis	8.73e-05	0.000553	CcSEcCtD
Mitotane—Paraesthesia—Hydrocortisone—psoriasis	8.67e-05	0.000549	CcSEcCtD
Mitotane—CYP11B1—Metabolism—NDUFA5—psoriasis	8.63e-05	0.00504	CbGpPWpGaD
Mitotane—Body temperature increased—Cyclosporine—psoriasis	8.59e-05	0.000544	CcSEcCtD
Mitotane—Vomiting—Mycophenolic acid—psoriasis	8.54e-05	0.000541	CcSEcCtD
Mitotane—Dyspepsia—Hydrocortisone—psoriasis	8.5e-05	0.000538	CcSEcCtD
Mitotane—Rash—Mycophenolic acid—psoriasis	8.47e-05	0.000536	CcSEcCtD
Mitotane—Dermatitis—Mycophenolic acid—psoriasis	8.46e-05	0.000536	CcSEcCtD
Mitotane—Pain—Prednisolone—psoriasis	8.45e-05	0.000536	CcSEcCtD
Mitotane—Hepatitis—Methotrexate—psoriasis	8.45e-05	0.000535	CcSEcCtD
Mitotane—Headache—Mycophenolic acid—psoriasis	8.41e-05	0.000533	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—NFKB1—psoriasis	8.4e-05	0.00491	CbGpPWpGaD
Mitotane—Decreased appetite—Hydrocortisone—psoriasis	8.39e-05	0.000532	CcSEcCtD
Mitotane—Body temperature increased—Mycophenolate mofetil—psoriasis	8.38e-05	0.000531	CcSEcCtD
Mitotane—Urinary tract disorder—Methotrexate—psoriasis	8.34e-05	0.000529	CcSEcCtD
Mitotane—Gastrointestinal disorder—Hydrocortisone—psoriasis	8.33e-05	0.000528	CcSEcCtD
Mitotane—Vision blurred—Prednisone—psoriasis	8.29e-05	0.000526	CcSEcCtD
Mitotane—Urethral disorder—Methotrexate—psoriasis	8.28e-05	0.000525	CcSEcCtD
Mitotane—Pain—Hydrocortisone—psoriasis	8.26e-05	0.000523	CcSEcCtD
Mitotane—Infection—Betamethasone—psoriasis	8.19e-05	0.000519	CcSEcCtD
Mitotane—Infection—Dexamethasone—psoriasis	8.19e-05	0.000519	CcSEcCtD
Mitotane—Paraesthesia—Triamcinolone—psoriasis	8.16e-05	0.000517	CcSEcCtD
Mitotane—Feeling abnormal—Prednisolone—psoriasis	8.15e-05	0.000516	CcSEcCtD
Mitotane—Visual impairment—Methotrexate—psoriasis	8.14e-05	0.000516	CcSEcCtD
Mitotane—Anaemia—Prednisone—psoriasis	8.13e-05	0.000515	CcSEcCtD
Mitotane—Shock—Betamethasone—psoriasis	8.11e-05	0.000514	CcSEcCtD
Mitotane—Shock—Dexamethasone—psoriasis	8.11e-05	0.000514	CcSEcCtD
Mitotane—Nervous system disorder—Betamethasone—psoriasis	8.09e-05	0.000512	CcSEcCtD
Mitotane—Nervous system disorder—Dexamethasone—psoriasis	8.09e-05	0.000512	CcSEcCtD
Mitotane—Thrombocytopenia—Betamethasone—psoriasis	8.08e-05	0.000512	CcSEcCtD
Mitotane—Thrombocytopenia—Dexamethasone—psoriasis	8.08e-05	0.000512	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.04e-05	0.0047	CbGpPWpGaD
Mitotane—Hypersensitivity—Cyclosporine—psoriasis	8e-05	0.000507	CcSEcCtD
Mitotane—Dyspepsia—Triamcinolone—psoriasis	8e-05	0.000507	CcSEcCtD
Mitotane—Nausea—Mycophenolic acid—psoriasis	7.98e-05	0.000505	CcSEcCtD
Mitotane—Feeling abnormal—Hydrocortisone—psoriasis	7.96e-05	0.000504	CcSEcCtD
Mitotane—Vertigo—Prednisone—psoriasis	7.91e-05	0.000501	CcSEcCtD
Mitotane—Eye disorder—Methotrexate—psoriasis	7.9e-05	0.0005	CcSEcCtD
Mitotane—Anorexia—Betamethasone—psoriasis	7.86e-05	0.000498	CcSEcCtD
Mitotane—Anorexia—Dexamethasone—psoriasis	7.86e-05	0.000498	CcSEcCtD
Mitotane—Hypersensitivity—Mycophenolate mofetil—psoriasis	7.81e-05	0.000495	CcSEcCtD
Mitotane—Asthenia—Cyclosporine—psoriasis	7.79e-05	0.000494	CcSEcCtD
Mitotane—Pain—Triamcinolone—psoriasis	7.77e-05	0.000493	CcSEcCtD
Mitotane—Hypotension—Dexamethasone—psoriasis	7.71e-05	0.000488	CcSEcCtD
Mitotane—Hypotension—Betamethasone—psoriasis	7.71e-05	0.000488	CcSEcCtD
Mitotane—Angiopathy—Methotrexate—psoriasis	7.67e-05	0.000486	CcSEcCtD
Mitotane—Body temperature increased—Hydrocortisone—psoriasis	7.63e-05	0.000484	CcSEcCtD
Mitotane—Asthenia—Mycophenolate mofetil—psoriasis	7.6e-05	0.000482	CcSEcCtD
Mitotane—Hypertension—Prednisone—psoriasis	7.6e-05	0.000481	CcSEcCtD
Mitotane—Feeling abnormal—Triamcinolone—psoriasis	7.49e-05	0.000475	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	7.44e-05	0.000471	CcSEcCtD
Mitotane—Diarrhoea—Cyclosporine—psoriasis	7.43e-05	0.000471	CcSEcCtD
Mitotane—Paraesthesia—Betamethasone—psoriasis	7.41e-05	0.000469	CcSEcCtD
Mitotane—Paraesthesia—Dexamethasone—psoriasis	7.41e-05	0.000469	CcSEcCtD
Mitotane—Mental disorder—Methotrexate—psoriasis	7.4e-05	0.000469	CcSEcCtD
Mitotane—CYP11A1—Metabolism—NDUFA5—psoriasis	7.38e-05	0.00431	CbGpPWpGaD
Mitotane—Malnutrition—Methotrexate—psoriasis	7.36e-05	0.000466	CcSEcCtD
Mitotane—CYP11B1—Metabolism—CYP2S1—psoriasis	7.33e-05	0.00429	CbGpPWpGaD
Mitotane—Hypersensitivity—Prednisolone—psoriasis	7.28e-05	0.000461	CcSEcCtD
Mitotane—Dyspepsia—Betamethasone—psoriasis	7.26e-05	0.00046	CcSEcCtD
Mitotane—Dyspepsia—Dexamethasone—psoriasis	7.26e-05	0.00046	CcSEcCtD
Mitotane—Diarrhoea—Mycophenolate mofetil—psoriasis	7.25e-05	0.000459	CcSEcCtD
Mitotane—Dysgeusia—Methotrexate—psoriasis	7.2e-05	0.000456	CcSEcCtD
Mitotane—Body temperature increased—Triamcinolone—psoriasis	7.19e-05	0.000455	CcSEcCtD
Mitotane—Dizziness—Cyclosporine—psoriasis	7.18e-05	0.000455	CcSEcCtD
Mitotane—Decreased appetite—Dexamethasone—psoriasis	7.17e-05	0.000454	CcSEcCtD
Mitotane—Decreased appetite—Betamethasone—psoriasis	7.17e-05	0.000454	CcSEcCtD
Mitotane—Infection—Prednisone—psoriasis	7.14e-05	0.000452	CcSEcCtD
Mitotane—Gastrointestinal disorder—Betamethasone—psoriasis	7.12e-05	0.000451	CcSEcCtD
Mitotane—Gastrointestinal disorder—Dexamethasone—psoriasis	7.12e-05	0.000451	CcSEcCtD
Mitotane—Hypersensitivity—Hydrocortisone—psoriasis	7.11e-05	0.000451	CcSEcCtD
Mitotane—Shock—Prednisone—psoriasis	7.07e-05	0.000448	CcSEcCtD
Mitotane—Pain—Betamethasone—psoriasis	7.05e-05	0.000447	CcSEcCtD
Mitotane—Pain—Dexamethasone—psoriasis	7.05e-05	0.000447	CcSEcCtD
Mitotane—Nervous system disorder—Prednisone—psoriasis	7.04e-05	0.000446	CcSEcCtD
Mitotane—Dizziness—Mycophenolate mofetil—psoriasis	7.01e-05	0.000444	CcSEcCtD
Mitotane—Skin disorder—Prednisone—psoriasis	6.98e-05	0.000442	CcSEcCtD
Mitotane—Vision blurred—Methotrexate—psoriasis	6.93e-05	0.000439	CcSEcCtD
Mitotane—Asthenia—Hydrocortisone—psoriasis	6.93e-05	0.000439	CcSEcCtD
Mitotane—Vomiting—Cyclosporine—psoriasis	6.91e-05	0.000438	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.88e-05	0.00402	CbGpPWpGaD
Mitotane—Rash—Cyclosporine—psoriasis	6.85e-05	0.000434	CcSEcCtD
Mitotane—Anorexia—Prednisone—psoriasis	6.85e-05	0.000434	CcSEcCtD
Mitotane—Dermatitis—Cyclosporine—psoriasis	6.84e-05	0.000434	CcSEcCtD
Mitotane—Headache—Cyclosporine—psoriasis	6.81e-05	0.000431	CcSEcCtD
Mitotane—Anaemia—Methotrexate—psoriasis	6.8e-05	0.000431	CcSEcCtD
Mitotane—Feeling abnormal—Dexamethasone—psoriasis	6.8e-05	0.000431	CcSEcCtD
Mitotane—Feeling abnormal—Betamethasone—psoriasis	6.8e-05	0.000431	CcSEcCtD
Mitotane—Vomiting—Mycophenolate mofetil—psoriasis	6.74e-05	0.000427	CcSEcCtD
Mitotane—Hypersensitivity—Triamcinolone—psoriasis	6.7e-05	0.000424	CcSEcCtD
Mitotane—Rash—Mycophenolate mofetil—psoriasis	6.68e-05	0.000423	CcSEcCtD
Mitotane—Dermatitis—Mycophenolate mofetil—psoriasis	6.68e-05	0.000423	CcSEcCtD
Mitotane—Headache—Mycophenolate mofetil—psoriasis	6.64e-05	0.000421	CcSEcCtD
Mitotane—Vertigo—Methotrexate—psoriasis	6.61e-05	0.000419	CcSEcCtD
Mitotane—Diarrhoea—Hydrocortisone—psoriasis	6.61e-05	0.000419	CcSEcCtD
Mitotane—Dizziness—Prednisolone—psoriasis	6.54e-05	0.000414	CcSEcCtD
Mitotane—Asthenia—Triamcinolone—psoriasis	6.52e-05	0.000413	CcSEcCtD
Mitotane—Body temperature increased—Dexamethasone—psoriasis	6.52e-05	0.000413	CcSEcCtD
Mitotane—Body temperature increased—Betamethasone—psoriasis	6.52e-05	0.000413	CcSEcCtD
Mitotane—Nausea—Cyclosporine—psoriasis	6.45e-05	0.000409	CcSEcCtD
Mitotane—Paraesthesia—Prednisone—psoriasis	6.45e-05	0.000409	CcSEcCtD
Mitotane—Dizziness—Hydrocortisone—psoriasis	6.38e-05	0.000404	CcSEcCtD
Mitotane—Dyspepsia—Prednisone—psoriasis	6.32e-05	0.000401	CcSEcCtD
Mitotane—Nausea—Mycophenolate mofetil—psoriasis	6.29e-05	0.000399	CcSEcCtD
Mitotane—CYP11A1—Metabolism—CYP2S1—psoriasis	6.27e-05	0.00367	CbGpPWpGaD
Mitotane—Decreased appetite—Prednisone—psoriasis	6.24e-05	0.000396	CcSEcCtD
Mitotane—Rash—Prednisolone—psoriasis	6.23e-05	0.000395	CcSEcCtD
Mitotane—Dermatitis—Prednisolone—psoriasis	6.23e-05	0.000395	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	6.22e-05	0.000394	CcSEcCtD
Mitotane—Headache—Prednisolone—psoriasis	6.19e-05	0.000392	CcSEcCtD
Mitotane—FDX1—Metabolism—CAT—psoriasis	6.18e-05	0.00362	CbGpPWpGaD
Mitotane—Vomiting—Hydrocortisone—psoriasis	6.14e-05	0.000389	CcSEcCtD
Mitotane—Rash—Hydrocortisone—psoriasis	6.09e-05	0.000386	CcSEcCtD
Mitotane—Dermatitis—Hydrocortisone—psoriasis	6.08e-05	0.000385	CcSEcCtD
Mitotane—Confusional state—Methotrexate—psoriasis	6.05e-05	0.000384	CcSEcCtD
Mitotane—Headache—Hydrocortisone—psoriasis	6.05e-05	0.000383	CcSEcCtD
Mitotane—Dizziness—Triamcinolone—psoriasis	6.01e-05	0.000381	CcSEcCtD
Mitotane—Infection—Methotrexate—psoriasis	5.96e-05	0.000378	CcSEcCtD
Mitotane—Feeling abnormal—Prednisone—psoriasis	5.92e-05	0.000375	CcSEcCtD
Mitotane—Asthenia—Betamethasone—psoriasis	5.92e-05	0.000375	CcSEcCtD
Mitotane—Asthenia—Dexamethasone—psoriasis	5.92e-05	0.000375	CcSEcCtD
Mitotane—Nervous system disorder—Methotrexate—psoriasis	5.89e-05	0.000373	CcSEcCtD
Mitotane—Thrombocytopenia—Methotrexate—psoriasis	5.88e-05	0.000372	CcSEcCtD
Mitotane—Nausea—Prednisolone—psoriasis	5.87e-05	0.000372	CcSEcCtD
Mitotane—Skin disorder—Methotrexate—psoriasis	5.83e-05	0.000369	CcSEcCtD
Mitotane—Vomiting—Triamcinolone—psoriasis	5.78e-05	0.000366	CcSEcCtD
Mitotane—Nausea—Hydrocortisone—psoriasis	5.73e-05	0.000363	CcSEcCtD
Mitotane—Rash—Triamcinolone—psoriasis	5.73e-05	0.000363	CcSEcCtD
Mitotane—Dermatitis—Triamcinolone—psoriasis	5.73e-05	0.000363	CcSEcCtD
Mitotane—Anorexia—Methotrexate—psoriasis	5.72e-05	0.000363	CcSEcCtD
Mitotane—Headache—Triamcinolone—psoriasis	5.69e-05	0.000361	CcSEcCtD
Mitotane—Body temperature increased—Prednisone—psoriasis	5.68e-05	0.00036	CcSEcCtD
Mitotane—Diarrhoea—Dexamethasone—psoriasis	5.64e-05	0.000358	CcSEcCtD
Mitotane—Diarrhoea—Betamethasone—psoriasis	5.64e-05	0.000358	CcSEcCtD
Mitotane—Hypotension—Methotrexate—psoriasis	5.61e-05	0.000355	CcSEcCtD
Mitotane—Dizziness—Betamethasone—psoriasis	5.45e-05	0.000346	CcSEcCtD
Mitotane—Dizziness—Dexamethasone—psoriasis	5.45e-05	0.000346	CcSEcCtD
Mitotane—Nausea—Triamcinolone—psoriasis	5.4e-05	0.000342	CcSEcCtD
Mitotane—Paraesthesia—Methotrexate—psoriasis	5.39e-05	0.000342	CcSEcCtD
Mitotane—Somnolence—Methotrexate—psoriasis	5.34e-05	0.000338	CcSEcCtD
Mitotane—Hypersensitivity—Prednisone—psoriasis	5.29e-05	0.000335	CcSEcCtD
Mitotane—Dyspepsia—Methotrexate—psoriasis	5.28e-05	0.000335	CcSEcCtD
Mitotane—Vomiting—Dexamethasone—psoriasis	5.24e-05	0.000332	CcSEcCtD
Mitotane—Vomiting—Betamethasone—psoriasis	5.24e-05	0.000332	CcSEcCtD
Mitotane—Decreased appetite—Methotrexate—psoriasis	5.22e-05	0.000331	CcSEcCtD
Mitotane—Rash—Betamethasone—psoriasis	5.2e-05	0.00033	CcSEcCtD
Mitotane—Rash—Dexamethasone—psoriasis	5.2e-05	0.00033	CcSEcCtD
Mitotane—Dermatitis—Betamethasone—psoriasis	5.2e-05	0.000329	CcSEcCtD
Mitotane—Dermatitis—Dexamethasone—psoriasis	5.2e-05	0.000329	CcSEcCtD
Mitotane—Gastrointestinal disorder—Methotrexate—psoriasis	5.18e-05	0.000328	CcSEcCtD
Mitotane—Headache—Dexamethasone—psoriasis	5.17e-05	0.000327	CcSEcCtD
Mitotane—Headache—Betamethasone—psoriasis	5.17e-05	0.000327	CcSEcCtD
Mitotane—Asthenia—Prednisone—psoriasis	5.15e-05	0.000327	CcSEcCtD
Mitotane—Pain—Methotrexate—psoriasis	5.13e-05	0.000325	CcSEcCtD
Mitotane—Feeling abnormal—Methotrexate—psoriasis	4.95e-05	0.000313	CcSEcCtD
Mitotane—Diarrhoea—Prednisone—psoriasis	4.91e-05	0.000311	CcSEcCtD
Mitotane—Nausea—Dexamethasone—psoriasis	4.9e-05	0.00031	CcSEcCtD
Mitotane—Nausea—Betamethasone—psoriasis	4.9e-05	0.00031	CcSEcCtD
Mitotane—FDX1—Metabolism—APOE—psoriasis	4.8e-05	0.00281	CbGpPWpGaD
Mitotane—Dizziness—Prednisone—psoriasis	4.75e-05	0.000301	CcSEcCtD
Mitotane—Body temperature increased—Methotrexate—psoriasis	4.75e-05	0.000301	CcSEcCtD
Mitotane—Vomiting—Prednisone—psoriasis	4.57e-05	0.000289	CcSEcCtD
Mitotane—Rash—Prednisone—psoriasis	4.53e-05	0.000287	CcSEcCtD
Mitotane—Dermatitis—Prednisone—psoriasis	4.52e-05	0.000287	CcSEcCtD
Mitotane—Headache—Prednisone—psoriasis	4.5e-05	0.000285	CcSEcCtD
Mitotane—Hypersensitivity—Methotrexate—psoriasis	4.42e-05	0.00028	CcSEcCtD
Mitotane—Asthenia—Methotrexate—psoriasis	4.31e-05	0.000273	CcSEcCtD
Mitotane—Nausea—Prednisone—psoriasis	4.27e-05	0.00027	CcSEcCtD
Mitotane—FDX1—Metabolism—PPARG—psoriasis	4.19e-05	0.00245	CbGpPWpGaD
Mitotane—Diarrhoea—Methotrexate—psoriasis	4.11e-05	0.00026	CcSEcCtD
Mitotane—Dizziness—Methotrexate—psoriasis	3.97e-05	0.000252	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.84e-05	0.00225	CbGpPWpGaD
Mitotane—Vomiting—Methotrexate—psoriasis	3.82e-05	0.000242	CcSEcCtD
Mitotane—Rash—Methotrexate—psoriasis	3.79e-05	0.00024	CcSEcCtD
Mitotane—Dermatitis—Methotrexate—psoriasis	3.78e-05	0.00024	CcSEcCtD
Mitotane—Headache—Methotrexate—psoriasis	3.76e-05	0.000238	CcSEcCtD
Mitotane—CYP11B1—Metabolism—CARM1—psoriasis	3.58e-05	0.00209	CbGpPWpGaD
Mitotane—Nausea—Methotrexate—psoriasis	3.57e-05	0.000226	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.35e-05	0.00196	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.29e-05	0.00192	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CARM1—psoriasis	3.06e-05	0.00179	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.86e-05	0.00167	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CAT—psoriasis	2.2e-05	0.00129	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CAT—psoriasis	1.88e-05	0.0011	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—APOE—psoriasis	1.71e-05	0.001	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PPARG—psoriasis	1.49e-05	0.000872	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—APOE—psoriasis	1.46e-05	0.000856	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PPARG—psoriasis	1.28e-05	0.000746	CbGpPWpGaD
